Oncology Institute Inc 最近的每股盈餘為 $-0.02,{eisBeating} $-0.07 的預期。
Oncology Institute Inc TOI 上一季度的收入表現如何?
Oncology Institute Inc 上一季度的收入為 $-0.02
Oncology Institute Inc 的收入預期是多少?
根據 5 位華爾街分析師的預測,Oncology Institute Inc 的收入預期範圍從 $167.48M 到 $149.74M
Oncology Institute Inc 的盈利品質評分是多少?
Oncology Institute Inc 的盈利品質評分為 B+/49.95322。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
Oncology Institute Inc 何時發布財報?
Oncology Institute Inc 的下一份財報預計在 2026-08-05 發布
Oncology Institute Inc 的預期收益是多少?
根據華爾街分析師的預測,Oncology Institute Inc 的預期收益為 $144.66M
Oncology Institute Inc 是否超出收益預期?
Oncology Institute Inc 最近的收益為 $147.44M,超出預期 預期。
關鍵數據
前收市價
$5.25
開盤價
$5.31
當日範圍
$5.15 - $5.36
52週區間
$2.01 - $5.57
交易量
2.1M
平均成交量
1.8M
股息收益率
--
每股盈餘 (TTM)
-0.45
市值
$520.8M
什麼是 TOI?
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 641 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.